Summary by Moomoo AI
Adam Lenkowsky, EVP and Chief Commercial Officer of Bristol-Myers Squibb (BMY), completed a series of transactions involving the company's common stock on March 10, 2024. Lenkowsky acquired a total of 15,016 shares through the exercise or conversion of derivative securities at no cost. Concurrently, he disposed of 8,892 shares, with some transactions involving a payment of exercise price or tax liability by delivering or withholding securities at a price of $53.79 per share. The total market value of the disposed shares amounted to $232,534.17. Following these transactions, Lenkowsky directly held 6,650 shares of common stock. Additionally, he has an indirect beneficial ownership of 9,550.52 shares, held through the BMS Savings and Investment Program and by his spouse.